cas 1006381-03-8|| where to buy (R)-4-methyl-1,3,2-dioxathiolane 2,2-dioxide

Nom du produit:(R)-4-methyl-1,3,2-dioxathiolane 2,2-dioxide

IUPAC Name:(4R)-4-methyl-1,3,2λ⁶-dioxathiolane-2,2-dione

Unité d'emballage	Stock disponible	Prix($)
CM199586-1g	in stock	ȃĲ
CM199586-5g	in stock	ǪŗǙ
CM199586-25g	in stock	ȃůƥ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1006381-03-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1006381-03-8; Formule moléculaire:C3H6O4S; Point de fusion:-; Code SMILES:C[C@H]1OS(OC1)(=O)=O; Densité:

: Numéro de catalogue:CM199586; Poids moléculaire:138.14; Point d'ébullition:; N° Mdl:; Stockage:

: Orforglipron; Obesity is becoming an increasingly serious public health problem globally, plaguing millions of people and significantly increasing their risk of chronic diseases such as diabetes and heart disease. In recent years, with the approval of new weight loss drugs such as Wegovy (Semaglutide) and Mounjaro (Tirzepatide), people's attention to this field has once again heated up, spawning an upsurge in the research and development of new treatments. There are currently nearly 70 obesity treatments in the research and development stage. Eli Lilly's Orforglipron is the world's first oral small molecule GLP-1RA to start Phase III clinical trials.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.